AETERNOOS · ONCOLOGY & NEURO
Educational CDS · clinician in the loop

Software as a Medical Device (SaMD) · Clinical Decision Support · Class IIa pathway · Multi-modal early signal escalation protocol · clinician-in-the-loop. Not CE-marked / not FDA-cleared until separately certified. Calculated signal for specialist confirmation — NOT a tissue diagnosis and not “Cancer detected”.

Signal engine · demo
72%Change-detection draft (clinician review)
The Slavko Principle does not diagnose cancer. It identifies patient-specific changes that may warrant timely clinical assessment. Scores below are educational CDS drafts for clinician confirmation — not pathology, not imaging reads, not emergency care. Life-threatening signs → 112 (EU). GPP SOS reserves demo imaging / oncology slots only after One-Click Confirm.
Synthetic Slavko alert (demo) — never “Cancer detected”.
Changed parameter
Biomarker kinetics vs personal baseline
Date
2026-08-20
Deviation
+74% educational CDS band (demo)
Confidence
Demo only
Physician action
Required — clinician decides

Multi-modal micro-signals

Risk progression · clinician bar

Serial change vs personal baseline (CDS draft)

Risk progression score72%

Fused Blood metabolomics shift + Thermal asymmetry + Biomarker kinetics + Voice/symptom drift. For specialist confirmation — not tissue diagnosis.

SaMD Class IIa pathway · One-Click Confirm & Route to Specialist · GPP SOS if score ≥ 70% after confirm.
Threshold watch: GPP SOS arms when risk ≥ 70% and clinician Confirms.

Audit log

Ready…
Upstream
Primary OS
Inputs
Thermal & Blood
GPP inbox
Hospital OS
Life module
Thermal surface